Guven, D. C. Et Al. 2023. The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.149, no.7 , 3599-3606.

Guven, D. C., Yekeduz, E., Erul, E., YAZGAN, S. C., Sahin, T. K., KARATAŞ, G., ... Aksoy, S.(2023). The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.149, no.7, 3599-3606.

Guven, Deniz Et Al. "The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study," JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.149, no.7, 3599-3606, 2023

Guven, Deniz C. Et Al. "The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study." JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.149, no.7, pp.3599-3606, 2023

Guven, D. C. Et Al. (2023) . "The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study." JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.149, no.7, pp.3599-3606.

@article{article, author={Deniz Can Guven Et Al. }, title={The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study}, journal={JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY}, year=2023, pages={3599-3606} }